Verition Fund Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-65,388
| Closed | -$188K | – | 2953 |
|
2025
Q1 | $188K | Sell |
65,388
-1,655
| -2% | -$4.77K | ﹤0.01% | 2398 |
|
2024
Q4 | $315K | Buy |
67,043
+29,400
| +78% | +$138K | ﹤0.01% | 2125 |
|
2024
Q3 | $134K | Buy |
+37,643
| New | +$134K | ﹤0.01% | 2260 |
|
2023
Q4 | – | Sell |
-19,212
| Closed | -$85.3K | – | 1995 |
|
2023
Q3 | $85.3K | Sell |
19,212
-40,337
| -68% | -$179K | ﹤0.01% | 1780 |
|
2023
Q2 | $197K | Buy |
59,549
+47,777
| +406% | +$158K | ﹤0.01% | 1591 |
|
2023
Q1 | $33.6K | Buy |
+11,772
| New | +$33.6K | ﹤0.01% | 1809 |
|
2021
Q4 | – | Sell |
-20,000
| Closed | -$564K | – | 1955 |
|
2021
Q3 | $564K | Buy |
+20,000
| New | +$564K | ﹤0.01% | 938 |
|